Galena buys Abstral in $15M Orexo deal; Novo Nordisk drug helps diabetes patients lose weight;

 @FierceBiotech: New special report: Biopharma's Top R&D Spenders - 2012. Report | Follow @FierceBiotech

@JohnCFierce: Updated AstraZeneca story. They buried the news on job cuts, thousands of relocations. Major upheaval. Story | Follow @JohnCFierce

@RyanMFierce: CRO buys chunk of mobile outfit behind virtual Pfizer trial. Article | Follow @RyanMFierce

> Orexo AB has sold Abstral (fentanyl) to Galena Biopharma ($GALE) for $10 million upfront and an additional $5 million within the first 12 months after signing, plus low double-digit royalties and milestone payments based on pre-specified sales levels. Release

> Israel-based Proteologics and GlaxoSmithKline ($GSK) have extended a research collaboration, originally for three years, for an additional year. Release

> Novo Nordisk's ($NVO) drug Victoza was successful at helping obese patients with Type 2 diabetes lose weight in a late-stage clinical trial. News

Pharma News

@FiercePharma: German pricing watchdog didn't like Bayer's data on Eylea. No add'l benefit, IQWiG says. Bayer will respond. Report | Follow @FiercePharma

@EricPFierce: Greece urged to take new twist on compulsory licenses to get hands on cheaper drugs. Story | Follow @EricPFierce

> Abbott CEO scores $25M, while new AbbVie chief nets $8M. More

> AstraZeneca to cut 1,600 jobs in global reshuffle. Story

> Apotex, Waxman take sides against pharma in Supreme Court generics cases. Article

Medical Device News

 @FierceMedDev: Med tech incubator InCube Labs raises $30M in Texas expansion. More | Follow @FierceMedDev

 @MarkHFierce: The cosmetic laser industry is consolidating, in a deal that is pretty big (for the device industry. Release | Follow @MarkHFierce

 @DamianFierce: India wants to launch two independent committees to make sure clinical trials are ethical. Story | Follow @DamianFierce

> Will Panasonic sell its healthcare division for $1.05B? News

> FDA intensifies warning on Stryker's Neptune devices. More

> Molecular biosensor diagnoses cancer by spotting high lactate levels. Story

CRO News

> Sunshine Biopharma on the hunt for CMO partner. Item

> India deepens effort to regulate clinical trials. Article

> Ex-Aptuit researcher convicted of cooking Roche, AZ data. More

> BioClinica, CoreLab merge after buyouts. Report

> After CRO sell-off, Radiant doubles down on trial sites. Story

Biotech IT News

> CRO buys chunk of mobile outfit behind virtual Pfizer trial. Story

> BioClinica CEO: No cuts planned after CoreLab merger, private equity sale. Report

> Spiral Genetics scores $3M VC round from major backer. Item

> Novartis eyes cancer patients with two mobile apps for iPhone, Android. Article

> Genomic analysis startup scores VA contract for major study. More

And Finally... The Mayo Clinic in Minnesota is the third U.S. leading clinical site to agree to hold a clinical trial for a Lou Gehrig's stem cell therapy developed by Israel-based BrainStorm. Story

Suggested Articles

Myovant’s uterine fibroid drug reduced blood loss in nearly three-quarters of patients, trouncing placebo in the second of two phase 3 studies.

The cystic fibrosis biotech unveiled Belous’ appointment alongside news of the promotion of Geoff Gilmartin to the CMO position.

The series C round is the latest in a series of boosts for Frequency’s attempts to tackle hearing loss through the activation of progenitor cells.